Cargando…
The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis
OBJECTIVE: This study aimed to assess (1) the prevalence of COVID-19 in patients with hip fracture; (2) the mortality rate of patients with hip fracture associated with COVID-19; (3) risk factors associated with mortality in patients with hip fracture; and (4) the effects of COVID-19 on surgical out...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AMDA - The Society for Post-Acute and Long-Term Care Medicine.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027948/ https://www.ncbi.nlm.nih.gov/pubmed/37062371 http://dx.doi.org/10.1016/j.jamda.2023.03.011 |
_version_ | 1784909826841640960 |
---|---|
author | Ding, Lifeng Wei, Jingzan Wang, Bin |
author_facet | Ding, Lifeng Wei, Jingzan Wang, Bin |
author_sort | Ding, Lifeng |
collection | PubMed |
description | OBJECTIVE: This study aimed to assess (1) the prevalence of COVID-19 in patients with hip fracture; (2) the mortality rate of patients with hip fracture associated with COVID-19; (3) risk factors associated with mortality in patients with hip fracture; and (4) the effects of COVID-19 on surgical outcomes of patients with hip fracture. DESIGN: Meta-analysis. SETTING AND PARTICIPANTS: Patients with hip fractures during COVID-19. METHODS: PubMed, Web of Science, and Embase were systematically reviewed. The outcomes included the prevalence of COVID-19, case fatality rate, 30-day mortality, cause of death, risk factors associated with the mortality of patients with hip fracture, time to surgery, surgical time, and length of hospitalization. Risk ratio or weight mean difference with 95% confidence intervals were used to pool the estimates. RESULTS: A total of 60 studies were included in this meta-analysis. The pooled estimate showed that the prevalence of COVID-19 was 21% in patents with hip fractures. Patients with hip fracture with COVID-19 had an increased 30-day mortality risk compared with those without the infection. The main causes of death were respiratory failure, COVID-19–associated pneumonia, multiorgan failure, and non–COVID-19 pneumonia. The hospitalization was longer in patients with COVID-19 when compared with those without the infection, but was shorter in patients during the pandemic period. The surgery time and time to surgery were not significantly different between patients during or before the pandemic period and in those with or without COVID-19. CONCLUSIONS AND IMPLICATIONS: The 30-day mortality rate was significantly higher in patients with hip fracture with COVID-19 infection than those without. Patients with COVID-19 had a higher all-cause mortality rate than those without. This information can be used by the medical community to guide the management of patients with hip fracture with COVID-19. |
format | Online Article Text |
id | pubmed-10027948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AMDA - The Society for Post-Acute and Long-Term Care Medicine. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100279482023-03-21 The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis Ding, Lifeng Wei, Jingzan Wang, Bin J Am Med Dir Assoc Review Article OBJECTIVE: This study aimed to assess (1) the prevalence of COVID-19 in patients with hip fracture; (2) the mortality rate of patients with hip fracture associated with COVID-19; (3) risk factors associated with mortality in patients with hip fracture; and (4) the effects of COVID-19 on surgical outcomes of patients with hip fracture. DESIGN: Meta-analysis. SETTING AND PARTICIPANTS: Patients with hip fractures during COVID-19. METHODS: PubMed, Web of Science, and Embase were systematically reviewed. The outcomes included the prevalence of COVID-19, case fatality rate, 30-day mortality, cause of death, risk factors associated with the mortality of patients with hip fracture, time to surgery, surgical time, and length of hospitalization. Risk ratio or weight mean difference with 95% confidence intervals were used to pool the estimates. RESULTS: A total of 60 studies were included in this meta-analysis. The pooled estimate showed that the prevalence of COVID-19 was 21% in patents with hip fractures. Patients with hip fracture with COVID-19 had an increased 30-day mortality risk compared with those without the infection. The main causes of death were respiratory failure, COVID-19–associated pneumonia, multiorgan failure, and non–COVID-19 pneumonia. The hospitalization was longer in patients with COVID-19 when compared with those without the infection, but was shorter in patients during the pandemic period. The surgery time and time to surgery were not significantly different between patients during or before the pandemic period and in those with or without COVID-19. CONCLUSIONS AND IMPLICATIONS: The 30-day mortality rate was significantly higher in patients with hip fracture with COVID-19 infection than those without. Patients with COVID-19 had a higher all-cause mortality rate than those without. This information can be used by the medical community to guide the management of patients with hip fracture with COVID-19. AMDA - The Society for Post-Acute and Long-Term Care Medicine. 2023-06 2023-03-21 /pmc/articles/PMC10027948/ /pubmed/37062371 http://dx.doi.org/10.1016/j.jamda.2023.03.011 Text en © 2023 AMDA - The Society for Post-Acute and Long-Term Care Medicine. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Ding, Lifeng Wei, Jingzan Wang, Bin The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis |
title | The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis |
title_full | The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis |
title_fullStr | The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis |
title_full_unstemmed | The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis |
title_short | The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis |
title_sort | impact of covid-19 on the prevalence, mortality, and associated risk factors for mortality in patients with hip fractures: a meta-analysis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027948/ https://www.ncbi.nlm.nih.gov/pubmed/37062371 http://dx.doi.org/10.1016/j.jamda.2023.03.011 |
work_keys_str_mv | AT dinglifeng theimpactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis AT weijingzan theimpactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis AT wangbin theimpactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis AT dinglifeng impactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis AT weijingzan impactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis AT wangbin impactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis |